UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024650
Receipt number R000028015
Scientific Title Epidemiological study of influenza virus infection: Household transmission of influenza infection after treatment of neuraminidase inhibitor
Date of disclosure of the study information 2016/10/31
Last modified on 2019/01/30 13:36:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Epidemiological study of influenza virus infection:
Household transmission of influenza infection after treatment of neuraminidase inhibitor

Acronym

Household transmission of influenza infection after treatment of neuraminidase inhibitor

Scientific Title

Epidemiological study of influenza virus infection:
Household transmission of influenza infection after treatment of neuraminidase inhibitor

Scientific Title:Acronym

Household transmission of influenza infection after treatment of neuraminidase inhibitor

Region

Japan


Condition

Condition

Influenza virus infection

Classification by specialty

Medicine in general Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigation of household transmission after neuraminidase inhibitor (either Peramivir, Oseltamivir, Zanamivir, Laninamivir ) treatment based on epidemiological data.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase



Assessment

Primary outcomes

Daily secondary infection rate in household setting

Key secondary outcomes

Overall secondary infection rate in household setting


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients diagnosed influenza A/B infection based on the rapid diagnosis test since 2010

Interval period for identifying 2ndary infection:24hr-7days between orignal and 2ndary infections

Key exclusion criteria

patients who showed different type or subtype of influenza virus infection compared to that of original infection

Target sample size

3400


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Nobuo Hirotsu

Organization

Hirotsu Clinic

Division name

Internal Medicine, Pediatrics

Zip code


Address

Hisamoto 3-6-1-212, Takatsu-ku, Kawasaki-shi, Kanagawa-ken, 231-0011, Japan

TEL

044-822-1933

Email

non-hirotsu@umin.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Nobuo Hirotsu

Organization

Hirotsu Clinic

Division name

Internal Medicine, Pediatrics

Zip code


Address

Hisamoto 3-6-1-212, Takatsu-ku, Kawasaki-shi, Kanagawa-ken, 231-0011, Japan

TEL

044-822-1933

Homepage URL


Email

non-hirotsu@umin.ac.jp


Sponsor or person

Institute

Hirotsu Clinic

Institute

Department

Personal name



Funding Source

Organization

Shionogi CO.,LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 10 Month 31 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://onlinelibrary.wiley.com/doi/abs/10.1111/irv.12590

Number of participants that the trial has enrolled


Results

please refer described below:
https://onlinelibrary.wiley.com/doi/abs/10.1111/irv.12590

https://rdcu.be/bfGcL

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2016 Year 09 Month 16 Day

Date of IRB


Anticipated trial start date

2016 Year 10 Month 31 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Retrospective research for influenza transmission in household setting


Management information

Registered date

2016 Year 10 Month 31 Day

Last modified on

2019 Year 01 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028015


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name